The AVENIO ctDNA Analysis Kits are a portfolio of three NGS liquid biopsy assays for oncology research. These assays provide an end-to-end tumor profiling and longitudinal tumor burden monitoring solution.
Features and Benefits of AVENIO ctDNA Analysis Kits
Flexibility to match the right assay optimized for the right research goal
Includes genes in the U.S. National Comprehensive Cancer Network (NCCN) Guidelines1
All four mutation classes (SNVs, indels, fusions and CNVs) in a single assay
Exceptional analytical performance supported by integrated digital error suppression (iDES) strategies combining molecular barcodes with in silico error suppression techniques2,3
Includes reagents for DNA extraction, library preparation and target enrichment, as well as bioinformatics and software required to analyze sequencing data and generate reports
Streamlined, end-to-end workflow from extraction to analysis and reporting in five days